Clinical Trial Update: Persistent Pain After Breast Cancer Treatment With Docetaxel

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating persistent pain following breast cancer treatment with docetaxel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Breast Neoplasms, Pain, Postoperative | Status: COMPLETED